Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
MicroScan Negative Panels Recall Issued Due to False Results September 5, 2013 Russell Maas Add Your CommentsRoughly 78,000 microbiology testing panels were recalled last month, after the manufacturer recognized that the devices may report false results that could cause a delay in therapy or administering of inappropriate antibiotics. ย On September 4, the FDA determined that a Siemens MicroScan Synergies plus and MicroScan rapID/S plus Negative Panels recall should be considered a Class I medical device recall, the most serious recall classification. The panels were originally recalled on August 21, when Siemens sent out an Urgent Field Safety Notice after learning the devices may show false results for imipenem and moropenem.The microbiology testing panels are used to detect infections. False results could lead to patients being prescribed the wrong antibiotics or result in delays in treatment.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe recall includes Synergies plus Negative following models and identification numbers; Urine Combo1 with part number 10444745 and part number B1025-106, combo 2 with material number 10444747 and part number B1025-108, Breakpoint Combo 7 with material number 10444748 and part number B1025-109, urine combo 2 with material number 10444749 and part number B1025-112, and Urine Combo 5 with material number 10483101 and part number B1025-115.The recalled products were manufactured by Siemens Healthcare Diagnostics Inc., of West Sacramento, California and were distributed throughout the US between July 11, 2011 and August 2, 2013.On August 21, 2013, Siemens sent out an Urgent Field Safety Notice to all affected customers identifying the products defect, problem, and the actions to be taken. Customers who have received this letter are encouraged to confirm their receipt of the Safety Notice and return the Field Correction Effectiveness Check Sheet.Class I recalls are the highest level of recall because there is a reasonable probability that the use of the product will cause serious adverse health consequences including death.In addition, Siemens is recommending customers to review previous test results and schedule routine follow-ups as they continue to monitor readings. Customers may contact Siemens at 1-800-677-7226 for further questions and concerns about the recall. Written by: Russell MaasManaging Editor & Senior Legal JournalistRussell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโs leading personal injury law firms and oversees the siteโs editorial strategy, including SEO and content development. Tags: Antibiotics, Medical Device Recall, SiemensMore Lawsuit Stories Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL July 31, 2026 Ocoopa Hand Warmer Recall Issued After 350 Burn Injuries, One Death July 31, 2026 Depo-Provera Settlement Information to Be Presented Through Town Hall Meeting July 30, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (Posted: yesterday)Lawyers involved in Boston Scientific spinal cord stimulator lawsuits have proposed an organizational structure for those chosen to represent the needs of all plaintiffs in the litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)Abbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients (07/23/2026)Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (07/16/2026) Depo-Provera Settlement Information to Be Presented Through Town Hall Meeting (Posted: 2 days ago)A federal judge has reviewed a Depo-Provera settlement agreement that could resolve thousands of brain tumor lawsuits, indicating that details of the confidential plan will be revealed to plaintiffs at a future hearing.MORE ABOUT: DEPO-PROVERA LAWSUITNew Study Adds to Evidence Depo-Provera Injections Cause Meningioma Brain Tumor Risks (07/13/2026)Depo-Provera Lawsuit Settlement Agreement May Resolve Eligible Meningioma Claims in MDL (06/15/2026)Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (06/05/2026) J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits (Posted: 3 days ago)A $5.5 billion settlement deal could resolve nearly 80,000 talcum powder cancer lawsuits that claim Johnson & Johnson products were contaminated with asbestos.MORE ABOUT: TALCUM POWDER CANCER LAWSUITSAdditional Talks To Settle Talcum Powder Cancer Lawsuits Set for April 13 (03/20/2026)Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J (02/16/2026)Evidence That Baby Powder Causes Ovarian Cancer Should Be Admissible At Trial: Report (01/22/2026)
Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (Posted: yesterday)Lawyers involved in Boston Scientific spinal cord stimulator lawsuits have proposed an organizational structure for those chosen to represent the needs of all plaintiffs in the litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITSpinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)Abbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients (07/23/2026)Boston Scientific Spinal Cord Stimulator Lawyers to Meet With MDL Judge for Initial Conference Aug. 5 (07/16/2026)
Depo-Provera Settlement Information to Be Presented Through Town Hall Meeting (Posted: 2 days ago)A federal judge has reviewed a Depo-Provera settlement agreement that could resolve thousands of brain tumor lawsuits, indicating that details of the confidential plan will be revealed to plaintiffs at a future hearing.MORE ABOUT: DEPO-PROVERA LAWSUITNew Study Adds to Evidence Depo-Provera Injections Cause Meningioma Brain Tumor Risks (07/13/2026)Depo-Provera Lawsuit Settlement Agreement May Resolve Eligible Meningioma Claims in MDL (06/15/2026)Depo-Provera Meningioma Side Effects Left Woman With Debilitating Migraines, Lawsuit Claims (06/05/2026)
J&J Agrees to $5.5B Talcum Powder Settlement Payout to Resolve Ovarian Cancer Lawsuits (Posted: 3 days ago)A $5.5 billion settlement deal could resolve nearly 80,000 talcum powder cancer lawsuits that claim Johnson & Johnson products were contaminated with asbestos.MORE ABOUT: TALCUM POWDER CANCER LAWSUITSAdditional Talks To Settle Talcum Powder Cancer Lawsuits Set for April 13 (03/20/2026)Ovarian Cancer Talcum Powder Lawsuit Results in $250K Verdict Against J&J (02/16/2026)Evidence That Baby Powder Causes Ovarian Cancer Should Be Admissible At Trial: Report (01/22/2026)